Sep 17, 2014
arGEN-X’ core patents protecting lead clinical candidates ARGX-110 and ARGX-111 receive accelerated grant in the United States
Sep 15, 2014
arGEN-X appoints Petercam NV as Liquidity Provider to facilitate trading on Euronext Brussels

Sept 29-30, 2014
New Developments in Cancer Biologics
Cambridge, UK
Oct 8-10, 2014
12th Annual Discovery on Target
Boston, MA, USA